Anzu Special Acquisition Corp I

Status: Deal Closed
U=S+W/3 W=S@11.5
IPO Proceeds, $M $425.00M
IPO Date Mar 2, 2021
CEO Dr. Whitney Haring-Smith
Left Lead BofA Securities
IPO Cash in Trust 100.0%
SPAC Tenor 24+6
IPO Sector Industrial

High-quality businesses with transformative technologies for industrial applications

IPO Geography Global
Target Company Envoy Medical
Deal Announced Apr 18, 2023
Deal Size, $M $150.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Sep 27, 2023
Amendment Vote Sep 29, 2023
Closing Date Sep 29, 2023
Formerly ANZU COCH COCHW

Sign up for Free Trial

No credit card required

Sign in for more on Anzu Special Acquisition Corp I:

  • Structure and cap table
  • 5 directors & officers
  • 38 filings and events
  • 2 underwriters
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Dr. Whitney Haring-Smith 36 CEO and Director
Daniel J. Hirsch 48 CFO and Director
Priya Cherian Huskins 48 Director
Susan J. Kantor 65 Director
Diane L. Dewbrey 58 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
BofA Securities Joint BR 25,200,000 units
Barclays Joint BR 16,800,000
42,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 38 filings.

Shareholders

Sign in to view shareholders 13F filing data.